Citation: C. Puozzo et al., SUPPORT TO PHASE-II CLINICAL-TRIALS OF ORAL VINORELBINE (VRL, NAVELBLNE((R))) BY POPULATION PHARMACOKINETICS (PKS) - A NEW TOOL TO FOLLOW DRUG-INDUCED TOXICITIES, Annals of oncology, 9, 1998, pp. 655-655
Authors:
SCHILLING T
FIEBIG HH
KERPELFRONIUS S
WINTERHALTER B
VARIOL P
TRESCA P
HEINRICH B
HANAUSKE AR
Citation: T. Schilling et al., CLINICAL-PHASE-I AND PHARMACOKINETIC TRIAL OF VINORELBINE ADMINISTERED AS SINGLE INTRAVENOUS BOLUS EVERY 21 DAYS IN CANCER-PATIENTS, Investigational new drugs, 14(4), 1996, pp. 371-378